The Indian Journal of Pediatrics

, Volume 62, Issue 5, pp 533–544 | Cite as

Nutrition and growth in patients with chronic liver disease

  • D. A. Kelly
Symposium: Hepatology—Part I


Protein energy malnutrition leading to growth failure is an inevitable consequence of chronic liver disease in childhood. Although the precise pathophysiology is not understood considerable progress has been made in understanding the mechanisms of fat malabsorption and protein turnover in liver disease.

There are many difficulties with the correct assessment of nutritional parameters in children with liver disease related to their abnormal body composition and energy expenditure and care needs to be taken with the interpretation on results.

The effects of malnutrition secondary to chronic liver disease are varied and include fat soluble vitamin deficiencies, generalised growth failure, impairment of gastrointestinal function, immunosuppression and hypotonia. It is now recognised that malnutrition is an important risk factor for liver transplantation and increases both mortality and morbidity.

Strategies to prevent or reverse malnutrition are now established and include the use of specific infant formulas based on low salt protein and an increased concentration of medium train triglyceride (50–70%).

Careful nutritional support in association with generous fat soluble vitamin supplementation may produce dramatic improvement in catch up weight gain but for those children in whom growth failure persists, the only management is liver transplantation.

Key words

Nutrition Chronic liver disease Growth 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Silverberg M, Davison M. Nutritional requirements of infants and children with liver disease.Amer J Clin Nutr 1970; 23: 604–613.PubMedGoogle Scholar
  2. 2.
    Weber A, Roy CC. The malabsorption associated with chronic liver disease in children.Paediatrics 1972; 50: 73–83.Google Scholar
  3. 3.
    Cohen MI, Gartner LM. The use of medium-chain triglycerides in the management of biliary atresia.J Pediatr 1971; 79: 379–384.PubMedCrossRefGoogle Scholar
  4. 4.
    Charlton CPJ, Buchanan E, Holden CEet al. Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy.Arch Dis Child 1992; 67: 603–607.PubMedCrossRefGoogle Scholar
  5. 5.
    Kaufmann SS, Murray ND, Wood RPet al. Nutritional suport for the infant with extrahepatic biliary atresia.J Pediatr 1987; 110: 679–686.CrossRefGoogle Scholar
  6. 6.
    Morgan AG, Kelleher J, Walker BEet al. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis.Gut 1976; 17: 113–118.PubMedCrossRefGoogle Scholar
  7. 7.
    McCullough AJ, Mullen KD, Smanik EJet al. Nutritional therapy and liver disease.Gastroenterol Clinics N Amer 1989; 18: 619–643.Google Scholar
  8. 8.
    Glasgow JFT, Hamilton JR, Sass-Kortsak A. Fat absorption in congenital obstructive liver disease.Arch Dis Child 1973; 48: 601–607.PubMedGoogle Scholar
  9. 9.
    Waterlow JC. Note on the assessment and classification of portein energy malnutrition in children.Lancet 2: 87–89.Google Scholar
  10. 10.
    Kelly DA, Kaufman SS, Shaw Bet al. Risk factors in gastrointestinal complications in children after orthotopic liver transplantation.Gut 1988; 29: A1476–1477.Google Scholar
  11. 11.
    Carey M, Small DM, Bliss CM. Lipid digestion and absorption.Annual Reviews of Physiology 1983; 45: 651–677.CrossRefGoogle Scholar
  12. 12.
    Badley BW, Murphy GM, Boucher IA, Sherlock S. Diminished micellar phase lipid in patients with chronic alcoholic liver disease and steatorrhoea.Gastroenterology 1970; 58: 781–789.PubMedGoogle Scholar
  13. 13.
    Swart GR, Zillikens MC, Van Vurre JK. Van den Berg JWO. Effect of late evening meal on nitorgne balance in patients with cirrhosis of the liver.Brit Med J 1989; 299: 1202–1203.PubMedGoogle Scholar
  14. 14.
    Glynn MJ, Powell-Tuck J, Reavely DAet al. High lipid parenteral nutrition improves portosystemic encephalopathy.J Parent Enteral Nutr 1988; 12: 457–461.Google Scholar
  15. 15.
    McKiernan PJ, Thomson JM, Dodge JAet al. Food energy requirements in biliary atresia.J Pediatr Gastro Nutr (In press).Google Scholar
  16. 16.
    Wilson SR, Amoroso P, Baker Aet al. Resting energy expenditure in children with liver disease.Proc Nutr Soc 1991; 50: 157A.Google Scholar
  17. 17.
    Shiau Y. Lipid digestion and absorption. In:Physiology of the Gastrointestinal Tract. Johnson LR ed. New York: Raven Press. 1987; 56: 1527–1556.Google Scholar
  18. 18.
    Glickman RM. Malabsorption and nutritional support. InClinics in Gastroenterology Sleisenger MH ed. 1983: 323–334.Google Scholar
  19. 19.
    Beath S, Johnson T, Willis Ket al. Superior absorption of medium chain triglycerides compared with conventional dietary long chain fats in children with chronic liver disease.Proc Nutr Soc 1993; 52: 252.Google Scholar
  20. 20.
    Gourley GR, Farrel PM, Odell G. Essential fatty acid deficiency after hepatic portoenterostomy for biliary atresia.Am J Clin Nutr 1982; 36: 1194–1199.PubMedGoogle Scholar
  21. 21.
    Beath S, Kelly DA, Booth IW. Essential fatty acid in babies with cholestatic liver disease.Gut 1993; S34: 8.Google Scholar
  22. 22.
    Spray CH, Beath SV, Willis KDet al. Docosohexanoeic acid (DHA) and visual function in children with fat malabsorption secondary to liver disease.Proc Nutr Soc 1995; in press.Google Scholar
  23. 23.
    Amedee-Manesme O, Furre HC, Alvarezfet al. Biochemical indicators of vitamin A depletionin children with cholestasis.Hepatology 1985; 6: 1143–1148.CrossRefGoogle Scholar
  24. 24.
    Rosenblum JL, Keating JP, Prensky ALet al. Aprogressive neurologic syndrome in children with chronic liver disease.N Engl J Med 1981; 304: 503–508.PubMedCrossRefGoogle Scholar
  25. 25.
    Daum F, Rosen JF, Roginsky Met al. 25-Hydroxycholecalciferol in the management of rickets associated with extra hepatic biliary atresia.J Pediatr 1976; 94: 1041–1043.Google Scholar
  26. 26.
    Roberts HR, Sederbaum AI. Liver and blood coagulation physiology and pathology.Gastroenterology 1972; 63: 297–320.PubMedGoogle Scholar
  27. 27.
    Haussler MR, McCain TA. Basic and clinical concepts related to vitamin D metabolism and action. Part I.N Engl J Med 1977; 297: 974–983.PubMedCrossRefGoogle Scholar
  28. 28.
    Kelly DA, Summerfield JA. Haemostasis in liver disease.Semin Liver Dis 1987; 7: 182–191.PubMedGoogle Scholar
  29. 29.
    Owen OE, Reichle FA, Mozzoli MAet al. Hepatic, gut and renal substrate flux rates in patients with hepatitis and cirrhosis.J Clin Invest 1981; 76: 1209–1217.Google Scholar
  30. 30.
    Kabadi UM, Eisenstein AB, Tucci J. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalisation on recovery.Am J Gastroenterol 1984; 79: 143–149.PubMedGoogle Scholar
  31. 31.
    Owen OE, Trapp VE, Richad GA. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis.J Clin Invest 1983; 72: 1821–1932.PubMedGoogle Scholar
  32. 32.
    Mullen KD, Denne SC, McCullough AJet al. Leucine metabolism in stable cirrhosis.Hepatology 1986; 6: 622–630.PubMedCrossRefGoogle Scholar
  33. 33.
    Weisdorf SA, Freese DK, Fath JJet al. Amino acid abnormalities in infants with extra hepatic biliary atresia.J Peadiatr Gastro Nutr 1987; 6: 860–864.Google Scholar
  34. 34.
    McCullough AJ, Tavil AS. Disordered energy and protein metabolims in liver disease.Semin Liver Dis 1991; 11: 265–277.PubMedGoogle Scholar
  35. 35.
    Munroe HN. Metabolism and function of amino acids in man—Overview and synthesis. InAmino acids, Metabolism and Medical applications. Blackburn GL, Grant JP, Young VR eds. John wright and PSFG 1983: 1–12.Google Scholar
  36. 36.
    Ruseel WE. GH Somatomedins in the liver.Semin LIv Dis 1985; 5: 46–58.Google Scholar
  37. 37.
    Clemmons DR, Underwood LE. Nutritional regulation of IGF1 and IGF binding proteins.Ann Rev of Nutr 1991; 11: 393–412.CrossRefGoogle Scholar
  38. 38.
    Bucuvalas JC, Cutfield W, Hornet al. Resistance to the growth promoting in metabolic effect of GH in children with chronic liver disease.J Pediatr 1990; 117: 397–402.PubMedCrossRefGoogle Scholar
  39. 39.
    Bucuvalas JC, Horn JA, Carlsson Let al. Growth hormone insensitivity associated with elevated circulating growth hormone binding protein in children with Alagille’s syndrome and short stature.J Clin Endocrinol Metabol 1994; 76: 1477–1482.CrossRefGoogle Scholar
  40. 40.
    Pierro A, Kovzko B, Carnielli Vet al. Resting energy expenditure is increased with infants with extra hepatic biliary atresia and cirrhosis.J Pediatr Surg 1989; 24: 534–538.PubMedCrossRefGoogle Scholar
  41. 41.
    McKiernan PJ, Magnay AR, Booth IW, Kelly DA. Determinants of resting energy expenditure in childhood liver disease.J Pediatr Gastro Nutr 1994; 19: 329–366.Google Scholar
  42. 42.
    Baker JP, Detsky AS, Wessen DEet al. Nutritional assessment a comparison of clinical judgement and objective measurements.N Engl J Med 1983; 306: 969–972.CrossRefGoogle Scholar
  43. 43.
    Goulet OJ, de Ville de Goyet J, Otte JB, Ricour C. Preoperative nutritional evaluation and support for liver transplantation in children.Transplant Proc 1987; 4: 3249–3255.Google Scholar
  44. 44.
    Sann L, Durand M, Picard J, Lasne Y, Bethenod M. Arm fat and muscle areas in infancy.Arch Dis Child 1988; 63: 256–260.PubMedGoogle Scholar
  45. 45.
    Meadows NJ, Till J, Leaf Aet al. Screening for intrauterine growth retardation using ratio of mid-arm curcumference to occipitiofrontal circumference.Brit Med J 1986; 292: 1039–1040.CrossRefGoogle Scholar
  46. 46.
    Schoeller DA, van Santen E, Peterson DWet al. Total body water measurement in humans with 180 and 2H labelled water.Am J clin Nutr 1980; 33: 2986–2993.Google Scholar
  47. 47.
    Vaisman N, Pencharz PB, Koren G, Johnson JK. Comparison of oral and intravenous administration of sodium bromide for extra-cellular water measurements.Am J Clin Nutr 1987; 46: 1–4.PubMedGoogle Scholar
  48. 48.
    Davies PSW, Preece MA, Hicks CJ, Halliday D. The predication of total body water using bioelectrical impedance in children and adolescents.Ann Hum Biol 1988; 15: 237–240.PubMedCrossRefGoogle Scholar
  49. 49.
    Meakins JL, Christou NV, Shizgal HM, MacLean LD. Therapeutic approaches to anergy in surgical patients Surgery and Levamisole.Ann Surg 1979; 19: 286–296.Google Scholar
  50. 50.
    Goodman DS. Vitamin A and retinoids in health and disease.N Engl J Med 1984; 310: 3023–3031.Google Scholar
  51. 51.
    Guggenheim MA, Ringel SP, Sliverman Aet al. Progressive Neuromuscular disease in children with chornic cholestasis and vitamin E deficiency; clinical and muscle biopsy findings and treatment with alcotocopherol.Ann NY Acad Sci 1982; 393; 84–93.PubMedCrossRefGoogle Scholar
  52. 52.
    Bishara S, Merin S, Cooper M,et al. Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoprotinemia.Brit J Ophthalm 1982; 66: 767–770.CrossRefGoogle Scholar
  53. 53.
    Alvarez F, Landrieu P, Laget Pet al. Nervous and ocular disorders in Children with cholestasis and Vitamin A and E deficinecies.Hepatology 1983; 3: 410–414.PubMedGoogle Scholar
  54. 54.
    Glasgow JFT, Thomas PS. The osteodystrophy of prolonged obstructive liver diseae in childhood.Acta Pediatr Scand 1976; 65: 57–64.Google Scholar
  55. 55.
    Yanofsky RA, Jackson VG, Lilly JRet al. Multiple coagulopathies of biliary atresia.Am J Haematol 1984; 16: 171–180.CrossRefGoogle Scholar
  56. 56.
    Beath SV, Brook G, Kelly DAet al. Successful liver transplantation in babies under 1 year.Brit Med J 1993; 307: 825–828.PubMedGoogle Scholar
  57. 57.
    Chong SKF, Lindridge J, Moniz C, Mowat A, Exocrine pancreatic insufficiency in syndromic paucity of interlobular bile ducts.J Pediatr Gastroenterol Nutr 1989; 9: 445–449.PubMedCrossRefGoogle Scholar
  58. 58.
    Beath S, Hooley I, Willis Ket al. Long chain triglyceride malabsorption and pancreatic function in children with protein energy malnutrition complicating severe liver disease.Proc Nutr Soc 1993; 52: 253A.Google Scholar
  59. 59.
    Sheldon GF, Perersen SR. Malnutrition and cardiopulmonary function: relation to oxygen transport.J Parent Enteral Nutr 1980; 4: 376–383.Google Scholar
  60. 60.
    Bidlack WR, Hamilton Smith C. The effect of nutritional factors on hepatic drug and toxicant metabolism.J Amer Diet Assoc 1984; 84: 892–898.Google Scholar
  61. 61.
    Moukarzel AA, Najm I, Vargas Jet al. Effective nutritional status and outcome of orthotopic liver transplantation in paediatric patinets.Transplant Proc 1990; 22: 1560–1563.PubMedGoogle Scholar
  62. 62.
    Beath SV, Booth IW, Kelly DA. Nutritional support in liver disease.Arch Dis Child 1993; 69: 545–549.PubMedGoogle Scholar
  63. 63.
    Sokol RJ, Nancy A, Butler-Simonit. Tocopheryl polyethylene glycol 1000 succinate therapy for vitamin E deficiency during chronic childhood cholestasis.J Pediatr 1987; 111: 830–836.PubMedCrossRefGoogle Scholar
  64. 64.
    Marchesini G, Zolin M, Dondi Cet al. Anticatabolic effect of branched chain amino enriched solutions in patients with liver cirrhosis.Hepatology 1982; 2: 420–425.PubMedGoogle Scholar
  65. 65.
    Weber FL, Bagby BS, Licate L, Kelsen SG. Effects of branched chain amino acids on nitrogen metabolism in patients with cirrhosis.Hepatology 1990; 11: 942–950.PubMedCrossRefGoogle Scholar
  66. 66.
    Blackburn GL, O’Keefe SJD. Nutrition in liver failure.Gastroenterology 1989; 97: 1049–1051.PubMedGoogle Scholar
  67. 67.
    Chin SE, Shepphard, Thomas BJet al. Nutritional support in children with end stage liver disease. A randomised crossover trial of branched chain amino acid supplement.Am J Clin Nutr 1992; 56: 158–163.PubMedGoogle Scholar
  68. 68.
    Spolidoro JV, Berquist WE, Pehlivanoglu Eet al. Growth acceleration in children after orthotopic liver transplantation.J Pediatr 1988; 112: 41–44.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1995

Authors and Affiliations

  • D. A. Kelly
    • 1
  1. 1.The Children’s HospitalBirminghamU.K.

Personalised recommendations